Changes in the autoimmune blistering response: A clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 653-655

  Maeda, J Y ^a   Moura, A K A ^a   Maruta, C W ^a   Santi, C G ^a   Prisayanh, P S ^b   Aoki, V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ACANTHOLYSIS; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE; BLISTER; CASE REPORT; CLINICAL FEATURE; EOSINOPHIL; EPIDERMIS; HISTOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; MALE; NEUTROPHIL; PEMPHIGOID; PEMPHIGUS FOLIACEUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SKIN BIOPSY;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; BIOPSY; BLISTER; FATAL OUTCOME; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PEMPHIGUS; PREDNISOLONE; TETRACYCLINE;

EID: 33746145898     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02174.x     Document Type: Article

References (10)

1. Dmochowski M, Hashimoto T, Garrod DR, Nishikawa T. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus. J Invest Dermatol 1993; 100: 380-1.
2. Joly P, Gilbert D, Thomine E et al. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. J Invest Dermatol 1997; 108: 469-75.
3. Karlhofer FM, Hashimoto T, Slupetzky K et al. 230-kDa and 190-kDa proteins in addition to desmoglein 1 as immunological targets in a subset of pemphigus foliaceus with a combined cell-surface and basement membrane zone immune staining pattern. Exp Dermatol 2003; 12: 646-54.
4. Iwatsuki K, Takigawa M, Hashimoto T et al. Can pemphigus vulgaris become pemphigus foliaceus? J Am Acad Dermatol 1991; 25: 797-800.
5. Kawana S, Hashimoto T, Nishikawa T, Nishiyama S. Changes in clinical features, histologic findings, and antigenic profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 1994; 130: 1534-8.
6. Sami N, Ahmed AR. Dual diagnosis of pemphigus and pemphigoid. Dermatology 2001; 202: 293-301.
7. Takahashi H, Anzai H, Suzuki Y et al. Parallel fluctuation of anti-desmoglein 3 and anti-BP 180 autoantibody titres in a patient of bullous pemphigoid. Clin Exp Dermatol 2004; 29: 608-11.
8. Chan LS, Vanderlugt CJ, Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110: 103-9.
9. Li N, Aoki V, Hans-Filho G et al. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003; 197: 1501-10.
10. Ding X, Aoki V, Mascaro JM et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997; 109: 592-6.